PL2753687T3 - Szczepy bakterii kwasu mlekowego i/lub bifidobakterii hamujących/zmniejszających wzrost różnych biotypów E. coli i różnych biotypów bakterii z rodzaju Clostridium - Google Patents
Szczepy bakterii kwasu mlekowego i/lub bifidobakterii hamujących/zmniejszających wzrost różnych biotypów E. coli i różnych biotypów bakterii z rodzaju ClostridiumInfo
- Publication number
- PL2753687T3 PL2753687T3 PL12780278T PL12780278T PL2753687T3 PL 2753687 T3 PL2753687 T3 PL 2753687T3 PL 12780278 T PL12780278 T PL 12780278T PL 12780278 T PL12780278 T PL 12780278T PL 2753687 T3 PL2753687 T3 PL 2753687T3
- Authority
- PL
- Poland
- Prior art keywords
- different biotypes
- clostridia
- bifidobacteria
- strains
- coli
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title 2
- 241000894006 Bacteria Species 0.000 title 1
- 241000186000 Bifidobacterium Species 0.000 title 1
- 241001112696 Clostridia Species 0.000 title 1
- 241000588724 Escherichia coli Species 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 235000014655 lactic acid Nutrition 0.000 title 1
- 239000004310 lactic acid Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01017—Lysozyme (3.2.1.17)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/167—Pentosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000475A ITRM20110475A1 (it) | 2011-09-09 | 2011-09-09 | Ceppi di batteri lattici e/o bifido batteri, opzionalmente addizionati di n-acetilcisteina e/o lisozima microincapsulato gastroprotetto, aventi attivita' di inibizione/riduzione della crescita di differenti biotipi di e.coli, incluso e.coli o157:h7 e |
| EP12780278.3A EP2753687B1 (en) | 2011-09-09 | 2012-09-10 | Strains of lactic acid bacteria and/or bifidobacteria inhibiting/reducing the growth of different biotypes of e. coli and different biotypes of clostridia |
| PCT/IB2012/001745 WO2013034975A1 (en) | 2011-09-09 | 2012-09-10 | Strains of lactic acid bacteria and/or bifidobacteria inhibiting/reducing the growth of different biotypes of e. coli and different biotypes of clostridia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2753687T3 true PL2753687T3 (pl) | 2019-02-28 |
Family
ID=44899092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12780278T PL2753687T3 (pl) | 2011-09-09 | 2012-09-10 | Szczepy bakterii kwasu mlekowego i/lub bifidobakterii hamujących/zmniejszających wzrost różnych biotypów E. coli i różnych biotypów bakterii z rodzaju Clostridium |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20150017128A1 (pl) |
| EP (1) | EP2753687B1 (pl) |
| JP (1) | JP6193858B2 (pl) |
| KR (1) | KR102219203B1 (pl) |
| CN (1) | CN103827291A (pl) |
| BR (1) | BR112014005139A2 (pl) |
| DK (1) | DK2753687T3 (pl) |
| ES (1) | ES2675127T3 (pl) |
| IT (1) | ITRM20110475A1 (pl) |
| PL (1) | PL2753687T3 (pl) |
| RU (1) | RU2624044C2 (pl) |
| WO (1) | WO2013034975A1 (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1403661B1 (it) | 2011-01-28 | 2013-10-31 | Probiotical Spa | Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali. |
| ITMI20110792A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia. |
| ITMI20110793A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati. |
| ITMI20110791A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri in grado di metabolizzare gli ossalati. |
| ITRM20110477A1 (it) | 2011-09-09 | 2013-03-10 | Giovanni Mogna | Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell |
| ITMI20111718A1 (it) | 2011-09-23 | 2013-03-24 | Probiotical Spa | Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali. |
| ITMI20130792A1 (it) * | 2013-05-14 | 2014-11-15 | Mofin S R L | Metodo per la prevenzione e/o riduzione dello sviluppo della listeria nell'industria casearia e prevenzione della listeriosi nell'uomo. |
| ITMI20130795A1 (it) * | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici e/o bifidobatteri per uso nel trattamento preventivo e/o curativo delle infezioni batteriche e/o delle infiammazioni del tratto urinario e/o della prostata che sono la causa di prostatiti e ipertrofia prostat |
| ITMI20130794A1 (it) * | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle vaginosi batteriche. |
| ITMI20130793A1 (it) * | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti. |
| EP3064072A1 (en) * | 2015-02-11 | 2016-09-07 | AB-Biotics S.A. | Probiotic lactobacillus strains for use in treating urinary tract infections |
| WO2017010851A1 (ko) * | 2015-07-16 | 2017-01-19 | 엘지이노텍(주) | 발광 소자 패키지 |
| ITUB20160207A1 (it) * | 2016-02-03 | 2017-08-03 | Probioresearch S R L | Nuovo ceppo di Lactobacillus reuteri con caratteristiche probiotiche, suo utilizzo e composizioni che lo contengono |
| MA45334A (fr) | 2016-03-24 | 2019-01-30 | Probiotical Spa | Composition bactérienne d'acide lactique pour le traitement d'infections vaginales bactériennes par gardnerella vaginalis et, éventuellement, d'infections fongiques concurrentes |
| BR112018076609B1 (pt) * | 2016-12-15 | 2023-02-14 | Société des Produits Nestlé S.A. | Composição alimentícia para animais de estimação, seus usos, e métodos não terapêutico para modular a quantidade e para medição de uma alteração na quantidade de pelo menos uma dentre bifidobacterium, lactobacillus ou clostridium perfringens |
| KR102244492B1 (ko) * | 2020-10-21 | 2021-04-26 | 대한민국(관리부서:국립수산과학원) | 신규 락토바실러스 속 균주 및 그의 용도 |
| KR20240102112A (ko) * | 2022-12-23 | 2024-07-03 | 주식회사 씨티씨바이오 | 대장염 예방 또는 치료활성 및 장내 유해균에 항균활성을 지닌 락토바실러스 및 그의 용도 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA39965C2 (uk) * | 1993-12-03 | 2001-07-16 | Лайфор Леборетріз Лтд | Вірусоцидний, бактерицидний та руйнуючий сперматозоїди вагінальний засіб і вагінальний супозиторій ( варіанти ) |
| US8828432B2 (en) * | 1996-10-28 | 2014-09-09 | General Mills, Inc. | Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles |
| FR2765078B1 (fr) * | 1997-06-27 | 1999-09-17 | Guyomarc H Nutrition Animale | Procede d'amelioration de l'efficacite d'un probiotique, preparation d'additifs alimentaires et aliments pour animaux la contenant |
| WO1999055326A1 (en) * | 1998-04-30 | 1999-11-04 | Vit-Immune, L.C. | Method of treatment of glutathione deficient mammals |
| PT1485463E (pt) * | 2002-03-21 | 2008-12-30 | Bifodan As | Estirpes de lactobacillus |
| JP4709838B2 (ja) * | 2004-08-05 | 2011-06-29 | アニドラル エス．アール．エル． | 葉酸産生ビフィドバクテリウム菌株、製剤およびこれらの用途 |
| ITMI20042189A1 (it) * | 2004-11-16 | 2005-02-16 | Anidral Srl | Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale |
| JP2006180836A (ja) * | 2004-12-28 | 2006-07-13 | Marudai Food Co Ltd | 食中毒菌感染を抑制する乳酸菌、ならびにそれを含む発酵物、食品および医薬組成物 |
| JP4050784B2 (ja) * | 2005-02-03 | 2008-02-20 | 株式会社Ｎｒｌファーマ | マトリックス型腸溶性・徐放性組成物 |
| JPWO2007020884A1 (ja) * | 2005-08-12 | 2009-02-26 | 明治乳業株式会社 | β−ディフェンシンを介した感染予防効果を有するビフィズス菌または乳酸菌とそれを含有する食品・医薬品組成物 |
| KR101530055B1 (ko) * | 2005-10-11 | 2015-06-29 | 프로바이오티컬 에스.피.에이. | 비알레르기성 프로바이오틱 박테리아 배양물의 제조 방법및 관련 용도 |
| JP5030960B2 (ja) * | 2005-10-24 | 2012-09-19 | ネステク ソシエテ アノニム | 食物繊維製剤及び投与方法 |
| WO2007100765A2 (en) * | 2006-02-28 | 2007-09-07 | Childrens Memorial Hospital | Lysozyme-modified probiotic components and uses thereof |
| US20080175899A1 (en) * | 2007-01-19 | 2008-07-24 | Ross Mairi R | Formulation for promoting sinus health in nasal cavities |
| EE05340B1 (et) * | 2008-05-13 | 2010-08-16 | O� Tervisliku Piima Biotehnoloogiate Arenduskeskus | Isoleeritud mikroorganismi tvi Lactobacillus plantarum Tensia DSM 21380 ja selle kasutamine antimikroobse ning verer?hku alandava probiootikuna ning ravimi valmistamiseks ning toiduaine realiseerimisaja pikendamiseks ja toiduaines kontamineerivatemi |
| KR101075557B1 (ko) * | 2008-12-03 | 2011-10-20 | 씨제이제일제당 (주) | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
| EP2248908A1 (en) * | 2009-05-05 | 2010-11-10 | Eurolactis Group S.A. | Probiotic microorganisms isolated from donkey milk |
| IT1397566B1 (it) * | 2009-05-27 | 2013-01-16 | Probiotical Spa | Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso |
| RU2012106516A (ru) * | 2009-07-27 | 2013-09-10 | Нестек С.А. | Питательные композиции, содержащие волокна и пробиотики |
| CN103079580B (zh) * | 2010-06-28 | 2015-04-29 | 益生菌股份公司 | 抑制分离自受腹绞痛影响的婴儿的产气性大肠菌类细菌的乳杆菌的应用 |
-
2011
- 2011-09-09 IT IT000475A patent/ITRM20110475A1/it unknown
-
2012
- 2012-09-10 ES ES12780278.3T patent/ES2675127T3/es active Active
- 2012-09-10 US US14/344,047 patent/US20150017128A1/en not_active Abandoned
- 2012-09-10 DK DK12780278.3T patent/DK2753687T3/en active
- 2012-09-10 KR KR1020147009472A patent/KR102219203B1/ko active Active
- 2012-09-10 JP JP2014529082A patent/JP6193858B2/ja active Active
- 2012-09-10 EP EP12780278.3A patent/EP2753687B1/en active Active
- 2012-09-10 CN CN201280044032.0A patent/CN103827291A/zh active Pending
- 2012-09-10 WO PCT/IB2012/001745 patent/WO2013034975A1/en not_active Ceased
- 2012-09-10 RU RU2014107771A patent/RU2624044C2/ru active
- 2012-09-10 BR BR112014005139A patent/BR112014005139A2/pt not_active IP Right Cessation
- 2012-09-10 PL PL12780278T patent/PL2753687T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2753687A1 (en) | 2014-07-16 |
| ITRM20110475A1 (it) | 2013-03-10 |
| CN103827291A (zh) | 2014-05-28 |
| US20150017128A1 (en) | 2015-01-15 |
| RU2014107771A (ru) | 2015-10-20 |
| KR20150000452A (ko) | 2015-01-02 |
| EP2753687B1 (en) | 2018-04-18 |
| KR102219203B1 (ko) | 2021-02-23 |
| JP2014526242A (ja) | 2014-10-06 |
| WO2013034975A1 (en) | 2013-03-14 |
| BR112014005139A2 (pt) | 2017-04-18 |
| JP6193858B2 (ja) | 2017-09-06 |
| DK2753687T3 (en) | 2018-05-28 |
| RU2624044C2 (ru) | 2017-06-30 |
| ES2675127T3 (es) | 2018-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2753687T3 (pl) | Szczepy bakterii kwasu mlekowego i/lub bifidobakterii hamujących/zmniejszających wzrost różnych biotypów E. coli i różnych biotypów bakterii z rodzaju Clostridium | |
| EP2705140B8 (de) | Neue milchsäurebakterien und diese enthaltende zusammensetzungen | |
| WO2013155468A3 (en) | Microbial strains and their use in animals | |
| PL2630265T3 (pl) | Szczepy bakterii kwasu mlekowego nadające teksturę | |
| HUE036025T2 (hu) | Új tejsav baktérium, gyógyszer, élelmiszer vagy ital, takarmány, amelyek az új tejsav baktériumot tartalmazzák | |
| EP3483259A4 (en) | NOVEL MILK ACID BACTERIA AND USE THEREOF | |
| IL226816B (en) | Composition and method for improving stability and extending shelf life of probiotic bacteria and food products thereof | |
| PL2685994T3 (pl) | Bakterie probiotyczne wykazujące aktywność przeciwutleniającą i ich zastosowanie | |
| PL2707478T3 (pl) | Probiotyczne szczepy bakterii i zawierająca je kompozycja symbiotyczna przeznaczona do żywności dla niemowląt | |
| ZA201409369B (en) | Composition comprising probiotic bacteria for the treatment of pathologies associated with alterations of the immune system | |
| DK2841557T3 (da) | Anvendelse af mælkesyrebakterier til fremstilling af fermenterede fødevareprodukter med forøget naturlig sødme | |
| WO2012112777A3 (en) | Biosynthesis of human milk oligosaccharides in engineered bacteria | |
| EP2531034A4 (en) | BIOCIDAL COMPOSITIONS FREE OF VOLATILE, MISCIBLE OR DISPERSIBLE ORGANIC COMPOUNDS IN WATER, CAPABLE OF MORE EFFICIENTLY INHIBITING NEGATIVE GRAM BACTERIAL STRAINS, AND PROCESS FOR THEIR PREPARATION | |
| PL2459203T3 (pl) | Bakterie kwasu mlekowego i bifidobakterie do leczenia endotoksemii | |
| EP2652141A4 (en) | MICROORGANISMS AND METHOD FOR PRODUCING 1,4-CYCLOHEXANDIMETHANOL | |
| PL2582787T3 (pl) | Bakterie kwasu mlekowego do jogurtu | |
| EP3875576A4 (en) | NOVEL LACTIC ACID BACTERIA AND USE THEREOF | |
| PL2276498T3 (pl) | Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii | |
| EP3255140A4 (en) | Lactic acid bacteria, natural immunoactivator and infection preventative/therapeutic derived from said lactic acid bacteria, and food/beverage | |
| PL3456334T3 (pl) | Bakterie kwasu mlekowego do stosowania dla zapobiegania ubytkowi masy kostnej u ssaków | |
| HUE038336T2 (hu) | Módosított gram-pozitív baktériumok és alkalmazásaik | |
| PT2655598T (pt) | Modulação de sabor por bioprocessamento utilizando estirpes de bactérias formadoras de sabor a nata | |
| BRPI1043371A2 (pt) | método para cultivar bactérias de ácido láctico, e, produto alimentício e de bebida. | |
| EP2401922A4 (en) | CULTURED MILK WITH LOW-LACTOSE CONTENT AND METHOD FOR THE PRODUCTION THEREOF | |
| HUE038830T2 (hu) | Módosított gram-pozitív baktériumok és alkalmazásaik |